• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains

    Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality

    Nutrition and Flavor: Formulating for Modern Product Preferences

    What Do Consumers Know About the Gut Microbiome?

    How Will the European Green Deal Impact Dietary Supplements?
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome

    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise

    Omega-3 Fatty Acids Linked to Reduced Episodes of Depression

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process

    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome

    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise

    Omega-3 Fatty Acids Linked to Reduced Episodes of Depression

    Fact or Myth: Antioxidants Negatively Impact Iron Absorption

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome

    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise

    Omega-3 Fatty Acids Linked to Reduced Episodes of Depression

    Fact or Myth: Antioxidants Negatively Impact Iron Absorption

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome

    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise

    Omega-3 Fatty Acids Linked to Reduced Episodes of Depression

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process

    Caffeine-Free Energy Supplement Linked to Alertness, Fatigue Benefits
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    PhytoGaia Inc

    BGG World

    Aiya America, Inc. (Aiya Matcha)

    KLK OLEO

    Verdure Sciences
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    PhytoGaia Inc

    BGG World

    Aiya America, Inc. (Aiya Matcha)

    KLK OLEO

    Verdure Sciences
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Shut Up & Take Your Meds

    While there has been progress in the movement of holistic approaches into the mainstream, U.S. healthcare is still by and large all about the meds.

    Shut Up & Take Your Meds
    Shut Up & Take Your Meds
    Related CONTENT
    • Getting to the Heart of Cardiovascular Health
    • Weighty Matters: Implications for Repeal of the Affordable Care Act
    • Pycnogenol May Normalize Cardiovascular Risk Factors in Perimenopausal Women
    • Oral Solid Dosage Outsourcing: Trends & Challenges
    • Healthcare Under Trump: What Can the Practitioner Channel Expect?
    Erik Goldman, Holistic Primary Care12.03.13
    “I was informed by the local insurance CEO that they will not pay me to get people well, only to give them a drug and get them out of my office in 5 minutes, and in the past 200 claims they may have paid 20. What is happening is criminal and no one is paying attention and no one seems to care. I have been in medicine all my life and licensed for 40 years and I am outraged. I am an excellent physician but the insurance took my business away! Where is our recourse?”

    This quote is from a seasoned osteopathic primary care physician answering a survey question about the biggest challenges doctors face in their practices today. It sums up just about everything that’s wrong with American medicine today.

    Healthcare has become a game of matching drugs to symptom patterns as quickly and “cost-efficiently” as possible, and then ensuring that people remain “compliant”—that is, they continue to take their meds, the keystone of most “disease management” protocols.

    While it’s true that there’s been considerable progress in the movement of holistic approaches from the fringes into the mainstream, U.S. healthcare is still by and large all about the meds. That trend is only going to intensify in the coming years.

    Andrew Weil, MD, founder of the University of Arizona’s hugely influential Fellowship in Integrative Medicine, and one of the patriarchs of the integrative medicine movement, described the situation very well at the Bravewell Collaborative’s annual awards event last month.

    Bravewell (www.bravewell.org), a philanthropic group founded by several wealthy families, has been instrumental in bringing a more holistic vision to conventional care settings over the last decade. The group, which will sunset itself over the next year, has also provided significant career development support for many thought-leaders, including Dr. Weil.

    Prevention Doesn’t Pay
    Though Dr. Weil acknowledged and applauded Bravewell’s many successes, he also voiced extreme frustration at the slow pace of progress.

    “I’ve been working for this transformation for over 40 years. As optimistic as I am in the long term, I think it’s going to be a long, hard road,” predicted the Bearded One. “Why can’t we do a better job of prevention? Simple! It doesn’t pay! As dysfunctional as American healthcare is, it is generating rivers of money that are flowing to a few pockets. Those vested interests want nothing to change, and their lobbying power is enormous. You cannot get elected to public office without making deals with those vested interests.”

    Those entrenched interests include a food and agriculture establishment that floods American life with unhealthy food options at artificially low prices—thanks to federal subsidies for things like corn syrup. “The fact is, people eat what’s cheapest and most available, and we’ve made the crappy stuff the cheapest and most available,” Dr. Weil told the Bravewell assembly.

    At the other end of the disease process is the drug industry, which is all too happy to take on the task of providing “solutions” for the problem of chronic diseases like diabetes, cardiovascular disease, obesity, behavioral disorders and a host of other conditions largely caused by lifestyle factors.

    The health insurance industry, though it’s wings are being clipped by the Affordable Care Act—arguably the only really good outcome of ObamaCare—has been equally zealous in its pursuit of profit through mediating the transactions through which people receive their “meds.”

    For much of the last 50 years, there’s been virtually no incentive for preventive medicine. The insurance version of “quality care” usually amounts to protocols aimed at matching people with the appropriate offerings from Big Pharma as efficiently as possible.

    The end result is the sort of frustration voiced by the doctor at the opening of this article.

    Questioning the ‘Evidence’
    Dr. Weil challenged the “complicity of the ‘evidence-based medicine’ community in this mess.”

    All-too-often, evidence based medicine (EBM) means pharma-based medicine, he said. The studies cited by advocates of EBM are often funded by drug companies, and almost always follow pharmaceutical logic in their study design, even if the subject under study differs significantly from the basic pharma “one problem, one molecule, one predictable outcome” model.

    According to Dr. Weil, some in the medical community are taking the EBM idea, with its insistence on randomized controlled trials, to the point of “religious fundamentalism.”

    “I see a big conflict between the EBM movement and the integrative medicine movement. Yes we need good science in integrative medicine, but not science that’s so skewed to the interests of the drug industry.”

    It would be one thing if the evidence being produced by the biomedical research establishment was reliable and replicable. Unfortunately, it is not.

    An eye-opening cover story in the October 19th edition of The Economist blows to bits many of our most “sacred” assumptions about the self-corrective process of science, and its ability to give us a reasonably accurate picture of reality.

    Titled “How Science Goes Wrong,” the article noted that researchers at Amgen, one of the world’s leading pharma/biotech companies in the oncology field, were able to reproduce only six out of 53 so-called “landmark” studies in cancer biology—that’s barely over 10%! And that’s after working closely with the researchers on the original studies to ensure that no methodological mistakes were introduced into the repeat experiments.

    Investigators at Bayer, the global pharma giant, were only able to reproduce the results of 25% of 67 “seminal” drug studies. The article goes on to cite an official at the National Institutes of Health, who estimated that at least 75% of all studies published in the biomedical literature are probably not replicable.

    Reproducibility is a cornerstone of the scientific method: if data from an experiment truly reflects reality, then multiple research groups following the same experimental protocol should obtain the same—or at least similar—outcomes.

    The Economist’s authors cited numerous reasons for the breakdown of good science: sloppy experiments, shoddy peer review, incessant academic pressure to publish newsworthy data, industrial interests intent on obtaining commercially useful study results and a general lack of interest in replicating—and thereby verifying—previous studies.

    Statin Guidelines Cause Heartburn
    The ongoing process of science, such as it is, results in conflicting messages to physicians and utter confusion for the general public.

    Witness the recent change in statin prescription guidelines forwarded jointly by the American Heart Association and the American College of Cardiology.

    For decades these guardians of conventional wisdom about heart disease pushed physicians to adhere to rigorous “evidence-based” standards focused on measuring lipid profiles, defining treatment targets for LDL cholesterol, and then focusing statin prescriptions to reach these goals.

    Now, the new guidelines insist that doctors no longer need to measure LDL or other lipids, and that pretty much anybody who looks like they’re at risk for cardiovascular disease should automatically get a statin prescription.

    Wow, so all those lipid tests we’ve been undergoing for the last 20 years are now unnecessary? How convenient, given that under healthcare reform, all the payers—whether federal or private sector—are looking for ways to cut costs.

    Think of the money saved if we just cut out all those millions of tests and just cut right to the statins! They’re safe, after all … so long as you don’t bother to take seriously the clinicians and their patients who report “anecdotally” that statins cause all sorts of musculoskeletal and cognitive side effects, and you ignore the data from large scale studies suggesting an increased risk of diabetes and congestive heart failure in people on long-term statin therapy.

    I have no way of knowing whether the authors of the new statin guidelines were in any way influenced by the rollout of healthcare reform, but the timing is certainly curious.

    Right out of the gate, the guidelines hit a major snag when Drs. Paul Ridker and Nancy Cook—two well-respected cardiology researchers—reported that the online risk assessment calculator that clinicians are supposed to use to determine who needs statin therapy, over-estimates risk of heart attacks by as much as 150%!

    The Ridker-Cook report sent shock waves through the cardiology community, and prompted a series of “behind-closed-doors” damage control sessions at the recent annual meeting of the American Heart Association in Dallas, TX.

    In the New York Times’ coverage of the debacle, Dr. Steven Nissen, chief of cardiology at the Cleveland Clinic, and a reliable voice of reason on scientific and public policy matters, said that he used the calculator to assess the risk of a healthy 60-year-old, non-smoking, non-diabetic black man with no obvious heart risk factors—i.e., total cholesterol of 150, HDL (good cholesterol) of 45, blood pressure of 125 mmHg.

    The calculator came to the conclusion that the man should be on a statin. “Something is terribly wrong,” Dr. Nissen told the Times’ Gina Kolata. If doctors follow the calculator, virtually every African American man over 65 would be put on a statin without question.

    That, I’m afraid, is the state of medical science and healthcare policy in the U.S. at this stage of the game. Disease prevention is all about getting as many people on meds as possible—and hoping nobody gets hurt enough to trigger a lawsuit.

    Lest we in the natural products world grin and gloat, let’s keep in mind the quantity of bogus science and shoddy manufacturing that goes on in our sector. It’s true that our industry has micro-doses of research funding compared to Big Pharma. But that’s not a license to fudge the rules and falsify the findings. In the long run, corruption of the scientific enterprise hurts us all—no matter who’s doing the corrupting.


    Erik Goldman is co-founder and editor of Holistic Primary Care: News for Health & Healing, a quarterly medical publication reaching about 60,000 physicians and other healthcare professionals nationwide. He is also co-producer, with Greg Stephens of Windrose Partners, of the Health Practitioner Marketing Forum, an executive level summit focused on challenges and opportunities in the health practitioner channel. The 2014 Forum will be held on April 2-4, 2014 at the Hotel Maya in Long Beach, CA. Visit www.HPMForum.com for more information. 
    Related Searches
    • Heart Disease
    • Healthcare
    • Health
    • Diabetes
    Related Knowledge Center
    • Regulations
    • Healthcare Trends
    Suggested For You
    Getting to the Heart of Cardiovascular Health Getting to the Heart of Cardiovascular Health
    Weighty Matters: Implications for Repeal of the Affordable Care Act Weighty Matters: Implications for Repeal of the Affordable Care Act
    Pycnogenol May Normalize Cardiovascular Risk Factors in Perimenopausal Women Pycnogenol May Normalize Cardiovascular Risk Factors in Perimenopausal Women
    Healthcare Under Trump: What Can the Practitioner Channel Expect? Healthcare Under Trump: What Can the Practitioner Channel Expect?
    Oral Solid Dosage Outsourcing: Trends & Challenges Oral Solid Dosage Outsourcing: Trends & Challenges
    Meta-Analysis Concludes EPA & DHA Omega-3s Lower Risk of Coronary Heart Disease Meta-Analysis Concludes EPA & DHA Omega-3s Lower Risk of Coronary Heart Disease
    Canola Oil May Help Reduce Belly Fat and Improve Metabolic Syndrome Canola Oil May Help Reduce Belly Fat and Improve Metabolic Syndrome
    Are You Aging Well? Are You Aging Well?
    MegaFood Unveils Bold Transparency Initiative MegaFood Unveils Bold Transparency Initiative
    An Interview with Shashank Upadhye of Amin Talati & Upadhye An Interview with Shashank Upadhye of Amin Talati & Upadhye
    Solid Dosage Manufacturing Trends Solid Dosage Manufacturing Trends
    Dr. Weil Assesses Nutrition & Health Dr. Weil Assesses Nutrition & Health
    A Guide to Winning the Nutraceuticals Market A Guide to Winning the Nutraceuticals Market
    American Botanical Council Celebrates 25 Years American Botanical Council Celebrates 25 Years
    American Botanical Council Celebrates 25 Years American Botanical Council Celebrates 25 Years

    Related Features

    • Cardiovascular Health | Consumer Trends | Dietary Supplements | Fatty Acids | Functional Foods & Beverages | Healthcare Trends | Healthy Aging | Herbs & Botanicals | Minerals | Omega-3s | Research | Vitamins
      Getting to the Heart of Cardiovascular Health

      Getting to the Heart of Cardiovascular Health

      With so many consumers at risk for heart disease, the need for supporting supplements and natural products is palpable.
      Sean Moloughney, Editor 04.03.17

    • Diabetes & Blood Sugar Management | Dietary Supplements | Healthcare Trends | Medical Nutrition
      Weighty Matters: Implications for Repeal of the Affordable Care Act

      Weighty Matters: Implications for Repeal of the Affordable Care Act

      Based on current trends, obesity-related medical costs could increase to $256 billion by 2030.
      Greg Stephens, Windrose Partners, & Sheila Campbell, PhD, RD 04.03.17

    • Breaking News | Cardiovascular Health | Herbs & Botanicals | Research | Research News | Supplier News | Women's Health

      Pycnogenol May Normalize Cardiovascular Risk Factors in Perimenopausal Women

      New research indicates Pycnogenol normalized elevated cholesterol, triglycerides, and blood pressure.
      03.21.17


    • Contract Manufacturing | Delivery & Dosage Technologies
      Oral Solid Dosage Outsourcing: Trends & Challenges

      Oral Solid Dosage Outsourcing: Trends & Challenges

      Despite the increasing number of biologics, oral solids remain the dominant dosage form in the pharmaceutical market.
      Tim Wright, Editor, Contract Pharma 03.01.17

    • Consumer Trends | Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      Healthcare Under Trump: What Can the Practitioner Channel Expect?

      Healthcare Under Trump: What Can the Practitioner Channel Expect?

      It remains to be seen how the new administration will treat the nutrition industry, but here’s what we know.
      Erik Goldman, Holistic Primary Care 03.01.17

    Loading, Please Wait..
    Trending
    • Study Examines Vitamin K2 Content In Cheese
    • Chenland Nutritionals Self-Affirms GRAS For Cumin UP60 Ingredient
    • Pycnogenol Evidenced To Have Skin Benefits In Dermatology Study
    • ADM And Benson Hill Partner To Scale High Protein Soy For U.S. Market
    • Omega-3 Fatty Acids Linked To Reduced Episodes Of Depression
    Breaking News
    • Vitamin K2 May Ameliorate Polycystic Ovary Syndrome
    • Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise
    • Omega-3 Fatty Acids Linked to Reduced Episodes of Depression
    • Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    • ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • A Growing Herbal Products Market Still Faces Formidable Threats, Challenges
    • Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality
    • Nutrition and Flavor: Formulating for Modern Product Preferences
    • Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains
    • How Will the European Green Deal Impact Dietary Supplements?
    • What Do Consumers Know About the Gut Microbiome?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome
    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise
    Omega-3 Fatty Acids Linked to Reduced Episodes of Depression
    Coatings World

    Latest Breaking News From Coatings World

    Nouryon Enters into Exclusive Agreement with Brenntag Specialties
    The BEHR & KILZ Brands Partner with Leanne Ford to Revitalize Her Historic American Home
    IGM Resins Acquires Litian
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    NeuroPace Becomes Exclusive U.S. Distributor of DIXI’s Product Line
    TransMed7 Achieves First-in-Human for Heron Soft Tissue Biopsy Devices
    West Pharmaceutical Services Invests in Latch Medical
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Societal CDMO Inks Land Sell Deal
    RoosterBio and AGC Biologics to Accelerate Manufacturing of Cell and Exosome Therapies
    WuXi Advanced Therapies Enters Licensing Agreement with Janssen
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Johnson & Johnson to Discontinue Global Sales of Talc-Based Baby Powder
    Dr. Squatch To Launch a 2nd Star Wars Soap Collection
    Neopac Wins 2 European Tube Manufacturers Association Awards
    Happi

    Latest Breaking News From Happi

    Coveteur Co-founder Erin Makes Foray into Skincare Space
    The Body Shop Canada Continues Expansion of New Concept Stores
    Nutrafol Expands Hair Care with Strand Defender Conditioner
    Ink World

    Latest Breaking News From Ink World

    Leadership Change in ALTANA’s ELANTAS Division
    Nazdar Highlights Ink Innovation at Labelexpo Americas 2022
    Cyngient, Imageworx Partner at Labelexpo for Security Labeling
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI partners with Convergen Energy at Labelexpo
    FINAT reports decrease in labelstock consumption during first half of 2022
    Color-Logic partners to feature metallics at autumn events
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Because Market Expands into Retail Stores
    Tranzonic Acquired by Private Investment Firm
    Monadnock Earns EcoVadis Gold Rating
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Integra LifeSciences Founder Dr. Richard Caruso Passes Away
    FDA Clears CTL Amedica's Navigation Instrument System
    FundamentalVR Raises $20 Million in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Appoints John Cooney to Lead Global Advocacy and Public Policy
    NMBS/SNCB Improves Security With HID Global’s Real-Time Location Service Technology
    onsemi Celebrates Expansion of Silicon Carbide Production Facility in New Hampshire

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login